{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:13:15Z","timestamp":1790784795936,"version":"4.1.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamadermatol.2022.1736","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:01:56Z","timestamp":1654095716000},"page":"779","source":"Crossref","is-referenced-by-count":73,"title":["Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy"],"prefix":"10.1001","volume":"158","author":[{"given":"Hanxi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjiao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"He","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"doi220023r1","doi-asserted-by":"publisher","first-page":"e978","DOI":"10.1016\/S2214-109X(20)30307-7","article-title":"Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions.","volume":"8","author":"Oluwasanu","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"1","key":"doi220023r2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9503","key":"doi220023r3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"doi220023r4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"doi220023r5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ijrobp.2010.01.031","article-title":"Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.","volume":"79","author":"Miller","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"doi220023r6","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0360-3016(00)00782-3","article-title":"Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.","volume":"48","author":"Fisher","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"doi220023r7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.radonc.2004.07.032","article-title":"Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? a randomised controlled trial.","volume":"73","author":"Wells","year":"2004","journal-title":"Radiother Oncol"},{"issue":"4","key":"doi220023r8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ijrobp.2014.06.033","article-title":"Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.","volume":"90","author":"Hindley","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"doi220023r9","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00520-013-1896-2","article-title":"Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.","volume":"21","author":"Wong","year":"2013","journal-title":"Support Care Cancer"},{"issue":"6","key":"doi220023r10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1188\/20.ONF.654-670","article-title":"ONS guidelines for cancer treatment-related radiodermatitis.","volume":"47","author":"Gosselin","year":"2020","journal-title":"Oncol Nurs Forum"},{"issue":"5","key":"doi220023r11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.prro.2021.05.005","article-title":"ASTRO editorial: ONS guidelines for cancer treatment-related radiodermatitis.","volume":"11","author":"Marquez","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"1-2","key":"doi220023r12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0027-5107(85)90109-5","article-title":"Detection and chemical identification of natural bio-antimutagens. a case of the green tea factor.","volume":"150","author":"Kada","year":"1985","journal-title":"Mutat Res"},{"issue":"2","key":"doi220023r13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/carcin\/22.2.287","article-title":"Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress.","volume":"22","author":"Katiyar","year":"2001","journal-title":"Carcinogenesis"},{"issue":"2","key":"doi220023r14","first-page":"148","article-title":"Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.","volume":"69","author":"Katiyar","year":"1999","journal-title":"Photochem Photobiol"},{"issue":"6","key":"doi220023r15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/jrr\/rru047","article-title":"Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression.","volume":"55","author":"Zhu","year":"2014","journal-title":"J Radiat Res"},{"key":"doi220023r16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-4-28","article-title":"The effects of tea extracts on proinflammatory signaling.","volume":"4","author":"Pajonk","year":"2006","journal-title":"BMC Med"},{"issue":"1058","key":"doi220023r17","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150665","article-title":"Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.","volume":"89","author":"Zhao","year":"2016","journal-title":"Br J Radiol"},{"issue":"30","key":"doi220023r18","doi-asserted-by":"crossref","first-page":"48607","DOI":"10.18632\/oncotarget.9495","article-title":"Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"doi220023r19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2019.02.022","article-title":"A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy.","volume":"137","author":"Zhao","year":"2019","journal-title":"Radiother Oncol"},{"key":"doi220023r20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.breast.2018.08.098","article-title":"Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: a prospective evaluation of a case series and review of the literature.","volume":"42","author":"De Rose","year":"2018","journal-title":"Breast"},{"issue":"13","key":"doi220023r21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"doi220023r22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijrobp.2010.05.065","article-title":"Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).","volume":"81","author":"Neben-Wittich","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"doi220023r23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canrad.2017.10.007","article-title":"Evaluation of acute skin toxicity of breast radiotherapy using thermography: results of a prospective single-centre trial.","volume":"22","author":"Maillot","year":"2018","journal-title":"Cancer Radiother"},{"issue":"1","key":"doi220023r24","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1080\/02656736.2019.1685685","article-title":"Relationships between the changes of skin temperature and radiation skin injury.","volume":"36","author":"Zhu","year":"2019","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"doi220023r25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ijrobp.2008.08.071","article-title":"Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation.","volume":"74","author":"Freedman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"doi220023r26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2018.02.006","article-title":"A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation.","volume":"101","author":"Ho","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"doi220023r27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/0378-6323.32755","article-title":"Topical betamethasone for prevention of radiation dermatitis.","volume":"73","author":"Omidvari","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"doi220023r28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-509X.29424","article-title":"Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study.","volume":"43","author":"Shukla","year":"2006","journal-title":"Indian J Cancer"},{"issue":"1","key":"doi220023r29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2016.11.013","article-title":"Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: a randomized double blinded study.","volume":"122","author":"Ulff","year":"2017","journal-title":"Radiother Oncol"},{"issue":"1","key":"doi220023r30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijrobp.2020.08.040","article-title":"Topical betamethasone valerate as a prophylactic agent to prevent acute radiation dermatitis in head and neck malignancies: a randomized, open-label, phase 3 trial.","volume":"109","author":"Menon","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"doi220023r31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2021.05.133","article-title":"Phase 3 Randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in patients with head and neck cancer receiving chemoradiation.","volume":"111","author":"Yokota","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"doi220023r32","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/cancers13235928","article-title":"Radiodermatitis and fibrosis in the context of breast radiation therapy: a critical review.","volume":"13","author":"Allali","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10099","key":"doi220023r33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"doi220023r34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort.","volume":"1","author":"Jagsi","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"doi220023r35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fct.2005.11.003","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations. part 2: dermal, acute and short-term toxicity studies.","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"doi220023r36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000241299","article-title":"Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.","volume":"22","author":"dal Belo","year":"2009","journal-title":"Skin Pharmacol Physiol"},{"issue":"4","key":"doi220023r37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002800050903","article-title":"Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.","volume":"43","author":"Dvorakova","year":"1999","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2792713\/jamadermatology_zhao_2022_oi_220023_1657583968.38728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:06:57Z","timestamp":1658329617000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2792713"}},"subtitle":["A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.1736","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}